相关实验视频
Updated: Feb 25, 2026

10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
21.4K
阿西普罗马在喘的小鼠模型中减少了气道收缩
Alembert Lino-Alvarado1, Maria Aparecida de Oliveira2, Carmen Silvia Moreno Serra2
1Biomedical Engineering Laboratory, Escola Politécnica, University of Sao Paulo, Sao Paulo, Brazil.
Clinical and experimental pharmacology & physiology
|February 23, 2026
概括
在喘模型中,acepromazine (ACP) 镇静可以影响呼吸机制. 这种镇静剂降低了呼吸道阻力和光滑肌肉反应能力,可能会混过敏喘研究的研究结果.
科学领域:
- 兽医药理学 兽医药理学 兽医药理学
- 呼吸系统生理学 呼吸系统生理学
- 免疫学 免疫学 免疫学
背景情况:
- 阿西普罗玛 (ACP) 是一种常见的兽医镇静剂,已知具有心血管作用.
- 它对呼吸机制的影响,尤其是在喘研究模型中,不太了解.
- 在临床前喘研究中,精确评估呼吸功能至关重要.
研究的目的:
- 为了研究acepromazine (ACP) 在过敏喘的小鼠模型中对呼吸机制的影响.
- 为了评估ACP对呼吸道光滑肌肉 (ASM) 的反应能力的影响,在体外.
- 确定ACP在喘研究中的潜在混影响.
主要方法:
- 在BALB/c小鼠中,用卵泡胺 (OVA) 敏感化诱发过敏喘.
- 小鼠接受了包括ACP (2.5 mg/kg) 在内的麻醉,以及胺和西拉.
- 呼吸机制被测量在体内使用强制振荡技术 (FOT) 后,甲胆 (MCh) 挑战.
- 呼吸道光滑肌肉 (ASM) 的反应在体外使用MCh.Ch.进行了评估.
主要成果:
- 在MCh挑战后对OVA敏感的小鼠中,ACP显著降低了牛顿电阻 (Rn).
- 在炎症的肺部中,ACP缓解了组织阻尼 (G) 和hysteresivity (η) 的增加.
- 在体外,ACP导致ASM的MCh度响应曲线向右转移,表明响应能力降低.
结论:
- 阿西普罗马 (ACP) 具有支气管扩张作用,并降低呼吸道光滑肌肉收缩性.
- 在喘模型中,ACP政府可能会误导对气道过度反应的评估.
- 仔细考虑镇静剂的选择对于喘研究中的呼吸机制研究的科学有效性至关重要.
相关概念视频
Antiasthma Drugs: Muscarinic Receptor Antagonists
1.9K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.9K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.8K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Antiasthma Drugs: Methylxanthines
1.8K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.8K

